Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, announced voting results from the Company's Annual Meeting of Stockholders, which was held earlier today. Approximately 74 percent of outstanding shares were represented at the meeting.
Help employers find you! Check out all the jobs and post your resume.
